HCA Healthcare, Inc. (NYSE:HCA) Shares Purchased by Todd Asset Management LLC

Todd Asset Management LLC lifted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 17.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 226,563 shares of the company's stock after purchasing an additional 33,271 shares during the period. HCA Healthcare comprises approximately 1.4% of Todd Asset Management LLC's holdings, making the stock its 9th biggest holding. Todd Asset Management LLC owned 0.08% of HCA Healthcare worth $61,326,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the stock. abrdn plc boosted its position in HCA Healthcare by 4.8% during the third quarter. abrdn plc now owns 164,419 shares of the company's stock worth $40,444,000 after acquiring an additional 7,476 shares during the last quarter. Soros Fund Management LLC acquired a new position in HCA Healthcare in the third quarter valued at $10,085,000. Handelsinvest Investeringsforvaltning acquired a new stake in HCA Healthcare in the 4th quarter worth about $1,100,000. DNB Asset Management AS lifted its holdings in shares of HCA Healthcare by 14.1% during the 4th quarter. DNB Asset Management AS now owns 60,682 shares of the company's stock worth $16,425,000 after acquiring an additional 7,476 shares during the period. Finally, Comerica Bank increased its position in HCA Healthcare by 623.3% during the third quarter. Comerica Bank now owns 43,502 shares of the company's stock worth $10,701,000 after purchasing an additional 37,488 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company's stock.

Insider Activity

In related news, SVP Chad J. Wasserman sold 876 shares of the company's stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $330.25, for a total transaction of $289,299.00. Following the completion of the transaction, the senior vice president now directly owns 1,576 shares in the company, valued at approximately $520,474. The sale was disclosed in a document filed with the SEC, which is available through this link. In other news, SVP Sammie S. Mosier sold 1,645 shares of the business's stock in a transaction that occurred on Monday, February 5th. The stock was sold at an average price of $312.00, for a total transaction of $513,240.00. Following the completion of the transaction, the senior vice president now directly owns 7,646 shares in the company, valued at $2,385,552. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP Chad J. Wasserman sold 876 shares of HCA Healthcare stock in a transaction on Wednesday, March 20th. The shares were sold at an average price of $330.25, for a total value of $289,299.00. Following the sale, the senior vice president now directly owns 1,576 shares in the company, valued at approximately $520,474. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 7,127 shares of company stock valued at $2,218,364. 1.60% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on the company. Deutsche Bank Aktiengesellschaft increased their target price on HCA Healthcare from $330.00 to $359.00 and gave the stock a "buy" rating in a research report on Friday, April 12th. Royal Bank of Canada boosted their target price on HCA Healthcare from $322.00 to $329.00 and gave the stock an "outperform" rating in a report on Monday, April 29th. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $335.00 price target on shares of HCA Healthcare in a research report on Wednesday, April 10th. StockNews.com raised shares of HCA Healthcare from a "buy" rating to a "strong-buy" rating in a research note on Thursday. Finally, TD Cowen lowered their price target on HCA Healthcare from $371.00 to $360.00 and set a "buy" rating for the company in a report on Tuesday, April 30th. Four research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $316.59.

HCA Healthcare Stock Down 0.3 %

Shares of HCA Healthcare stock traded down $1.08 during trading on Friday, reaching $307.76. The company had a trading volume of 1,044,934 shares, compared to its average volume of 1,189,320. The company has a debt-to-equity ratio of 29.26, a quick ratio of 1.02 and a current ratio of 1.16. The company has a market cap of $81.40 billion, a price-to-earnings ratio of 15.34, a price-to-earnings-growth ratio of 1.44 and a beta of 1.66. HCA Healthcare, Inc. has a fifty-two week low of $215.96 and a fifty-two week high of $335.83. The firm's fifty day moving average is $322.22 and its 200-day moving average is $298.18.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its earnings results on Friday, April 26th. The company reported $5.36 EPS for the quarter, topping the consensus estimate of $5.01 by $0.35. The company had revenue of $17.34 billion during the quarter, compared to analyst estimates of $16.81 billion. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. The business's revenue was up 11.2% on a year-over-year basis. During the same quarter last year, the firm earned $4.93 EPS. On average, analysts anticipate that HCA Healthcare, Inc. will post 20.74 EPS for the current year.

HCA Healthcare announced that its board has authorized a stock repurchase program on Tuesday, January 30th that authorizes the company to repurchase $6.00 billion in shares. This repurchase authorization authorizes the company to reacquire up to 7.4% of its shares through open market purchases. Shares repurchase programs are usually a sign that the company's leadership believes its stock is undervalued.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 28th. Shareholders of record on Friday, June 14th will be issued a $0.66 dividend. The ex-dividend date is Friday, June 14th. This represents a $2.64 dividend on an annualized basis and a yield of 0.86%. HCA Healthcare's dividend payout ratio is currently 13.16%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.